OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Internal Medicine is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Internists or specialists-that is the question!	419
Abdominal aortic aneurysm and gas in the kidney in a diabetes patient	174
Telemedicine in internal medicine: A statement by the European Federation of Internal Medicine.	171
The role of age in recognizing cognitive impairment in the emergency department	122
Impact of adherence to EULAR quality indicators on the quality of life of patients with systemic lupus erythematosus	112
Non-pharmacological home remedies used by primary care patients	101
Effects of the implementation of the dynamic silver code in the emergency department	82
The higher the serum albumin, the better? Findings from the PRACTICE study	81
The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study)	74
Trial sequential analysis methodology for interpreting meta-analytical findings	69
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis	65
Clinical characteristics of BRASH syndrome: Systematic scoping review	62
Impact of thoracoabdominal imaging on diagnosis and management in patients with suspected infective endocarditis	61
Recurrence rates and risk factors for recurrence after first episode of acute pancreatitis: A systematic review and meta-analysis	59
The impact of hypoalbuminemia on the long-term prognosis of patients with acute heart failure: The modifying role of carbohydrate antigen 125	54
How the theory of centralized aerobic-anaerobic energy balance compensation explains sudden cardiac death in young athletes	52
Risk trajectory of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis	52
Reconsidering the Edelman equation: impact of plasma sodium concentration, edema and body weight	51
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care	51
Concerns regarding result analysis and the corresponding risk of pulmonary embolism severity and in-hospital mortality	48
Heart failure: An autopsy case	46
No evidence of a “July Effect” on mortality	45
The peculiarities of COVID-19 in older people: Considerations after two years	45
Prevalence of post-COVID symptoms one-year after SARS-CoV-2 infection in patients with interstitial lung disease	44
Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time?	43

A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation	42
Prognostic impact of hypertension grading	42
Hyperhomocysteinemia in patients with acute porphyrias: a possible effect of ALAS1 modulation by siRNAm therapy and its control by vitamin supplementation	41
Natural history of ‘silent’ atrial fibrillation from subclinical to asymptomatic: State of the art and need for research	40
A woman with purple-brown skin lesions after immunosuppressive therapy	40
Aspirin and P2Y12 inhibitors in treating COVID-19	38
Effects of statins on clinical outcomes in hospitalized patients with COVID-19	38
Health differences between adults with and without intellectual disabilities at the internal medicine department: A first step to improve awareness of intellectual disabilities among healthcare profes	37
Structural evolution of severe acute respiratory syndrome coronavirus 2: Implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccines	37
Refining risk assessment for intra-abdominal infections in immunocompromised intensive care unit patients	37